PubMed دسترسی آزاد

E-Cigarette Directory Laws, Sales, and Product Availability From 3 Early-Adopting US States.

استودیوی صوتی مقاله

پخش حرفه‌ای فارسی و انگلیسی

در حال بررسی نسخه‌های صوتی ذخیره‌شده…

صوت تولیدشده با هوش مصنوعی است. برای کاربرد علمی یا درمانی، متن و منبع اصلی را بررسی کنید.
خواندن هوشمند فارسی و انگلیسی در حال آماده‌سازی صداهای مرورگر…
تنظیم صدای طبیعی و سرعت

صداهایی که در نامشان «Natural»، «Neural» یا «Online» دیده می‌شود معمولاً طبیعی‌ترند. انتخاب صدا به صداهای نصب‌شده در ویندوز و مرورگر شما بستگی دارد.

چکیده اصلی

IMPORTANCE: Flavored e-cigarettes are the most-used tobacco product among US youths and young adults. The US Food and Drug Administration (FDA) has authorized only 45 e-cigarette products, while thousands remain under review. Some states have enacted laws permitting sales of non-FDA-authorized products listed on state directories, but the impact of these laws is unknown. OBJECTIVES: To evaluate the association of directory laws with e-cigarette sales and product availability over time in Alabama, Oklahoma, and Louisiana, the first states to enact these laws. DESIGN, SETTING, AND PARTICIPANTS: This cross-sectional study applied a synthetic difference-in-differences approach to assess state-level e-cigarette retail sales from the 4-week period ending January 31, 2021, through the 4-week period ending April 20, 2025. Alabama, Oklahoma, and Louisiana were compared with synthetic controls constructed from 31 states without directories, assessing changes before and after directory publication. Data were analyzed August 1, 2025, to July 20, 2026. EXPOSURE: Implementation of directory laws. MAIN OUTCOMES AND MEASURES: The primary outcome consisted of per capita e-cigarette nicotine sales, calculated as units sold × e-liquid volume × nicotine concentration, summed across products per state-month and divided by state population. Product availability was a secondary outcome, defined as the number of distinct products sold monthly in each state. Analyses were conducted overall and stratified by flavor and product type. RESULTS: A total of 1904 state-month observations were included in the analysis. No associations of e-cigarette nicotine sales or product availability with directory listings were observed in Alabama or Oklahoma, where flavored disposables remained dominant. In Louisiana, the law was associated with a significant reduction in sales relative to synthetic controls (average treatment effect [ATT], -38.29% [95% CI, -53.10% to -18.80%). However, event-study analyses showed this decline was temporary, with the estimated treatment effect equal to -19.46% (95% CI, -27.32% to -10.76%) immediately after publication and reaching -63.43% (95% CI, -74.32% to -47.92%) in July 2024, 8 months after implementation. Sales then rebounded and the decrease became statistically nonsignificant by October 2024 as unlisted flavored disposables and menthol cartridges drove sales. In contrast, product availability in Louisiana declined persistently with an ATT of -53.55% (95% CI, -65.67% to -37.14%). In all states, more than half of sales were for unlisted products by the end of the study period. CONCLUSIONS AND RELEVANCE: In this cross-sectional study, directory laws in early-adopter states did not produce lasting declines in flavored e-cigarette sales. These findings suggest that directory laws instead might divert resources from evidence-based tobacco control strategies.

متن کامل اصلی

نسخه دارای مجوز در منبع علمی در دسترس است.

لینک مستقیم از metadata منبع گرفته شده و در تب جدید باز می‌شود.

باز کردن متن کامل
در همین زیرشاخه

مقاله‌های مرتبط

PubMed2026

Comparative Barriers and Enablers in ASEAN Long-Term Care Systems: Insights From the 2025 Regional Policy Dialogue and Policy Recommendations for Equitable Active Ageing.

OBJECTIVE: To examine barriers and enablers to equitable long-term care (LTC) across ASEAN-Plus Three (APT) economies and to propose a framework for equitable active ageing, contributing to Sustainable Development Goals 3 and 10. METHODS: A qualitative participatory-observation study was conducted during the 2025 Regional Policy Dialogue on Inclusive and Equitable Care Systems. Reflexive thematic analysis, read through a life-course le…

PubMed2026

Secondary Use of Health Data in Canada and the European Union: Expectations, Frictions and the Politics of Scale.

In this article, we trace expectations associated with efforts to promote secondary use of health data in Canada and the European Union. In Canada, we focus on initiatives enabling cross-jurisdictional data access in a highly devolved federal system with parallel commitments to Indigenous data sovereignty. In the EU, we focus on the European Health Data Space, a new regulatory regime intended to facilitate access to health data for cli…

PubMed2026

A tale of two realities: how do policymakers and general practitioners perceive the performance of primary health networks in Australia.

BACKGROUND: As the major regional primary health care (PHC) organisations in Australia, Primary Health Networks (PHNs) are expected to coordinate health care for patients and respond to local health needs. To evaluate their success, it is important to examine both policy practitioners' and GPs' perceptions of PHNs' role, structure and performance. METHODS: Thirty-six semi-structured interviews were conducted, including 15 interviews wi…

PubMed2026

An overview of international reference values for vitamin E intake - similarities and differences in derivation.

PURPOSE: The scientific knowledge for the essential fat-soluble vitamin E (VitE) remains inconclusive. There is still a lack of valid status parameters and deficiency symptoms for insufficient intake. Therefore, the derivation of a dietary reference value (DRV) for VitE is challenging and differs between the different organizations and countries. The aim of the current paper is to provide an overview of selected international DRVs and …